3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
7
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
Myeloid
1
Conditions
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
nilotinib
4
ruxolitinib
2
ponatinib
2
venetoclax
1
selinexor
1
navitoclax
1
midostaurin
1
fludarabine phosphate
1
asciminib
1
Whole-Body Irradiation
1
Transplantation
1
Tacrolimus
1
Mycophenolic Acid
1
Imatinib Mesylate
1
Dasatinib
1
Cytarabine
1
Cord Blood Stem Cell Transplantation
1
Busulfan
1
Bone Marrow Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
navitoclax
×
Myeloid
×
Clear all
NCT03592576
2024-05-06
Expanded Access to Navitoclax
AbbVie
No longer available